We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$150B
1-Year Est. Return
40.08%
This Fund
S&P 500
This Quarter
Est. Return
+11.66%
1 Year Est. Return
+40.08%
3 Year Est. Return
+113.08%
5 Year Est. Return
+141.06%
10 Year Est. Return
+565.41%
AUM
$229B
AUM Growth
+$120B
(+109%)
Cap. Flow
+$101B
Cap. Flow
% of AUM
44.02%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,953
New
141
Increased
1,630
Reduced
80
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.08B |
| 2 |
Apple
AAPL
|
+$3.05B |
| 3 |
Amazon
AMZN
|
+$2.11B |
| 4 |
JPMorgan Chase
JPM
|
+$1.29B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$276M |
| 2 |
Medtronic
MDT
|
+$230M |
| 3 |
Illinois Tool Works
ITW
|
+$124M |
| 4 |
XPEL
XPEL
|
+$123M |
| 5 |
Shopify
SHOP
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.43% |
| 2 | Healthcare | 12.6% |
| 3 | Financials | 12.53% |
| 4 | Industrials | 10.92% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Cytosorbents Corp
CTSO
$18.1M
| $3.99M | ﹤0.01% |
180,180
+105,045
| +140% | +$3.12M |
|
1102
Halliburton
HAL
$28.8B
| $3.97M | ﹤0.01% |
109,936
+63,195
| +135% | +$2.43M |
|
1103
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$619M
| $3.97M | ﹤0.01% |
86,452
+43,226
| +100% | +$1.92M |
|
1104
Viking Therapeutics
VKTX
$3.44B
| $3.96M | ﹤0.01% |
212,998
+128,687
| +153% | +$1.68M |
|
1105
Liberty Media Series C
FWONK
$23.9B
| $3.91M | ﹤0.01% |
61,982
+29,580
| +91% | +$1.93M |
|
1106
Celanese
CE
$5.14B
| $3.88M | ﹤0.01% |
24,992
+12,412
| +99% | +$1.62M |
|
1107
SK Telecom
SKM
$13.6B
| $3.84M | ﹤0.01% |
179,462
+125,343
| +232% | +$2.65M |
|
1108
Invesco DB Commodity Index Tracking Fund
DBC
$1.96B
| $3.8M | ﹤0.01% |
172,494
+86,247
| +100% | +$2.06M |
|
1109
Fox Class A
FOXA
$27.8B
| $3.8M | ﹤0.01% |
128,068
+18,878
| +17% | +$571K |
|
1110
Huntington Ingalls Industries
HII
$11B
| $3.79M | ﹤0.01% |
14,592
+10,273
| +238% | +$2.4M |
|
|
NVMI
1111
Nova
NVMI
$10.8B
| $3.78M | ﹤0.01% |
+27,500
| New | +$3.18M |
|
1112
Robert Half
RHI
$3.8B
| $3.73M | ﹤0.01% |
42,460
+37,926
| +836% | +$3.01M |
|
1113
iShares Core US Aggregate Bond ETF
AGG
$137B
| $3.71M | ﹤0.01% |
37,358
+22,463
| +151% | +$2.14M |
|
1114
Immunovant
IMVT
$7.51B
| $3.68M | ﹤0.01% |
87,440
+35,618
| +69% | +$1.31M |
|
1115
Endava
DAVA
$154M
| $3.67M | ﹤0.01% |
+47,196
| New | +$2.92M |
|
1116
Reinsurance Group of America
RGA
$16.2B
| $3.64M | ﹤0.01% |
22,500
+11,867
| +112% | +$1.85M |
|
1117
Korn Ferry
KFY
$4.22B
| $3.63M | ﹤0.01% |
61,124
+29,060
| +91% | +$1.48M |
|
1118
Fortis
FTS
$27.5B
| $3.6M | ﹤0.01% |
87,052
+50,095
| +136% | +$2.02M |
|
1119
Bruker
BRKR
$9.24B
| $3.59M | ﹤0.01% |
48,876
+24,657
| +102% | +$1.58M |
|
1120
KeyCorp
KEY
$22.1B
| $3.58M | ﹤0.01% |
248,698
+143,637
| +137% | +$1.71M |
|
1121
VeriSign
VRSN
$27B
| $3.58M | ﹤0.01% |
17,376
+7,992
| +85% | +$1.66M |
|
1122
Synchrony
SYF
$24.4B
| $3.57M | ﹤0.01% |
93,602
+41,392
| +79% | +$1.31M |
|
1123
Wendy's
WEN
$1.34B
| $3.55M | ﹤0.01% |
182,240
+88,520
| +94% | +$1.7M |
|
1124
Capital One
COF
$125B
| $3.55M | ﹤0.01% |
27,042
+14,964
| +124% | +$1.61M |
|
1125
Shinhan Financial Group
SHG
$38.3B
| $3.53M | ﹤0.01% |
114,218
+47,832
| +72% | +$1.31M |
|
Similar funds
Neuberger Berman Group's Q4 2023 Portfolio in Review
As of Q4 2023, Neuberger Berman Group held 1,953 positions worth $229B, up 109% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Neuberger Berman Group deployed $101B of net new capital in Q4 2023, opening 141 new positions and adding to 1,630 existing holdings. Its largest new stake was Avantis Emerging Markets Equity ETF: 972,278 shares worth $54.8M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Medtronic, an estimated $230M trimmed.
- Neuberger Berman Group's largest Q4 2023 buy was Avantis Emerging Markets Equity ETF: 972,278 shares worth $54.8M.
- Neuberger Berman Group added most to Microsoft in Q4 2023, an estimated $4.08B increase.
- Neuberger Berman Group's biggest Q4 2023 reduction was Medtronic, cutting an estimated $230M.
- Neuberger Berman Group fully exited Activision Blizzard in Q4 2023, selling an estimated $276M.
- Neuberger Berman Group's ten largest holdings make up 17% of its $229B portfolio in Q4 2023.
- Neuberger Berman Group opened 141 new positions and closed 90 in Q4 2023.
- Neuberger Berman Group's portfolio value rose 109% quarter-over-quarter to $229B.
Based on Neuberger Berman Group's 13F filing for Q4 2023, filed 9 Feb 2024.